Prof. Dr. Jürgen K. Rockstroh
International HIV physician, viral hepatitis researcher, and guideline leader reviewing patient-facing HIV and HCV content for clinical accuracy and evidence integrity.
A Senior HIV Physician Reviewing Patient-Facing HIV and HCV Content
Prof. Dr. Jürgen K. Rockstroh is Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn / University Hospital Bonn in Germany. His public institutional profiles identify him as a long-standing HIV clinician and researcher with major work in antiretroviral therapy, HIV disease in haemophiliacs, and HIV with viral hepatitis co-infection.
His HIV and hepatitis work is unusually relevant for SunnyPharma® because much of the site’s medical education covers antiretroviral therapy, access barriers, medication cost questions, generic ARV formulations, PrEP/PEP, and hepatitis C direct-acting antiviral treatment. Rockstroh’s clinical and academic record directly overlaps with HIV treatment, hepatitis C, HBV/HCV screening, co-infection management, and guideline-based infectious disease care.
As Medical Editor for SunnyPharma®, Prof. Rockstroh reviews patient-facing content for medical accuracy, guideline alignment, source quality, and clear separation between evidence, clinical interpretation, and access-related commentary. His role is editorial review and medical oversight; SunnyPharma® content remains educational and does not replace individualized care from a licensed clinician.
For HIV and hepatitis content, credibility depends on saying exactly what the evidence supports — no more, no less. Patients deserve accuracy, context, and a clear distinction between medical facts and access decisions.
Peer-Reviewed HIV and Hepatitis C Publications
Prof. Rockstroh has authored and co-authored extensive peer-reviewed literature on HIV treatment, viral hepatitis, and HIV/HCV co-infection. Representative works include:
Leadership, Guideline and Public Health Contributions
Prof. Rockstroh’s professional profile includes HIV clinical leadership, guideline involvement, hepatitis co-infection expertise, and European HIV testing policy work. Representative public verification points:
-
Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn
-
European AIDS Clinical Society leadership, including EACS guideline panel activity and EACS presidency
-
International AIDS Society governing council service
-
Research focus on antiretroviral therapy, HIV disease in haemophiliacs, and HIV/hepatitis co-infection
-
Recipient of the Federal Cross of Merit awarded by the Federal Republic of Germany
How Prof. Rockstroh Reviews SunnyPharma® Content
Every article assigned for medical review is checked against three reference layers in sequence: (1) current FDA-approved or EMA-authorized prescribing information where applicable, (2) current HIV and viral hepatitis guideline statements from recognized authorities including DHHS/NIH, EACS, IAS-USA, AASLD/IDSA, WHO, and EASL, and (3) peer-reviewed literature on clinical efficacy, drug resistance, adherence, safety, co-infection, real-world outcomes, and treatment-experienced populations.
Conflict of interest disclosure. Prof. Rockstroh’s publicly filed conference and publication disclosures include consultancy, advisory, and speaker relationships with pharmaceutical manufacturers active in HIV and viral hepatitis, which is typical of senior academic clinicians in this field. His current disclosures are available through the public profiles linked on this page. SunnyPharma® accepts no funding, advertising, or sponsorship from any pharmaceutical manufacturer, and no manufacturer has any role in which articles he reviews or how he reviews them.
Independence boundary. SunnyPharma® is an independent health education platform — not a pharmacy, not a seller, and not affiliated with any pharmaceutical manufacturer. Prof. Rockstroh’s university and clinical roles are separate from any SunnyPharma® editorial review work. No SunnyPharma® content is directed to patients under his direct clinical care.